Related Experiment Video

Updated: Aug 22, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Fibrinogen and fibrin clot structure in diabetes

Emma J Dunn1, Robert A S Ariëns

  • 1Academic Unit of Molecular Vascular Medicine, Research School of Medicine, University of Leeds, UK.

Herz
|September 2, 2004
PubMed

Insights

Diabetes elevates cardiovascular disease risk beyond known factors, with fibrinogen playing a key role. Understanding hyperfibrinogenemia mechanisms in diabetes is crucial for reducing vascular risk.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Hematology

Background:

  • Diabetes mellitus significantly increases cardiovascular disease (CVD) risk.
  • Classic CVD risk factors do not fully explain this elevated risk.
  • Fibrinogen is a potent independent CVD risk marker, likely contributing to diabetes-associated atherosclerosis.

Purpose of the Study:

  • To explore the role of fibrinogen in diabetes-related cardiovascular risk.
  • To investigate the multifactorial etiology of hyperfibrinogenemia in diabetes.
  • To understand how diabetes influences atherothrombotic risk beyond fibrinogen levels.

Main Methods:

  • Review of current evidence on fibrinogen and diabetes.
  • Exploration of potential mechanisms linking insulin, insulin resistance, and inflammation to hyperfibrinogenemia.
  • Consideration of diabetes-induced alterations in fibrin clot structure and function.

Main Results:

  • Fibrinogen is a significant risk marker for CVD in the general population and likely in diabetes.
  • Hyperfibrinogenemia in diabetes is multifactorial, with insulin, insulin resistance, and inflammation implicated, particularly in type 2 diabetes.
  • Diabetes may increase atherothrombotic risk through mechanisms beyond elevated fibrinogen, including changes to fibrin clot properties.

Conclusions:

  • Diabetes confers an increased vascular risk that is not entirely explained by traditional risk factors.
  • Elevated fibrinogen levels and altered fibrin clot characteristics are key contributors to this risk.
  • Further research into the underlying mechanisms is needed to develop targeted interventions for reducing vascular complications in diabetic patients.

More Related Videos

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...